T. Bird
Consigliere Generale presso VERU INC.
Profilo
T.
Gary Bird currently works at Veru, Inc., as Executive VP-Quality & Regulatory Affairs from 2020.
Dr. Bird also formerly worked at GTx, Inc., as Director-Corporate Quality.
Dr. Bird received his graduate degree from Mississippi State University.
Posizioni attive di T. Bird
| Società | Posizione | Inizio |
|---|---|---|
| VERU INC. | Consigliere Generale | 01/01/2020 |
Precedenti posizioni note di T. Bird
| Società | Posizione | Fine |
|---|---|---|
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Corporate Officer/Principal | - |
Formazione di T. Bird
| Mississippi State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VERU INC. | Health Technology |
| Aziende private | 1 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
- Borsa valori
- Insiders
- T. Bird
